ArticleDigestive diseases and sciences2025
Immunohistochemistry to Highlight Intraepithelial Lymphocytes in Formalin-Fixed and Frozen Duodenal Biopsies: Comparability of Results and Cut-Off Revision.
Article in Digestive diseases and sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Incidental finding of esophageal eosinophilia in patients investigated for suspected celiac disease: results from a pediatric retrospective study.European journal of pediatrics · 2026Article
- Insightful Investigations into the Applications of Immunohistochemistry to Highlight Intraepithelial Lymphocytes in Formalin-Fixed and Frozen Duodenal Biopsies: Comparability of Results and Cut-Off Revision.Digestive diseases and sciences · 2026Article
- Advantages of anti-endomysial evaluation in children with low titers of anti-transglutaminase antibodies: A retrospective study.Journal of pediatric gastroenterology and nutrition · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
aimTcRγδ+ and CD3+ intraepithelial lymphocytes (IELs) counting is crucial for celiac disease (CD) diagnosis. TcRγδ+ staining by immunohistochemistry (IHC) is usually performed on frozen optimal-cutting-temperature-compound (OCT)-embedded sections that are not routinely stored in most hospitals. We implemented an IHC protocol for TcRγδ+ IELs on formalin-fixed paraffin-embedded (FFPE) duodenal sections, and performed it along with CD3 staining to estimate cut-offs useful for CD diagnosis for both markers.
methods40 untreated-CD and 60 No-CD controls for whom both FFPE and OCT-embedded duodenal samples were available have been included in the study. IHC for TcRγδ+ and CD3+ IELs was performed on all sections and stained cells were counted per mm of epithelium.
resultsIn FFPE sections, both TcR-γδ+ (20.6 ± 12.7) and CD3+ (60.3 ± 29.3) IELs were higher in CD than non-CD (1.9 ± 1.7; 23.9 ± 14.8, respectively; p < 0.0001). ROC curve analysis allowed to identify the following cut-offs to discriminate active CD from No-CD: 4 TcRγδ+ and 40 CD3+ IELs/mm of epithelium on FFPE, 4 TcRγδ+ IELs and 34 CD3+ IELs on OCT-embedded-sections. Cut-offs represented the 95th percentile of No-CD controls. Correlation analyses between FFPE and OCT showed a highly positive correlation for both markers (r-Pearson coefficient 0.7, p < 0.001).
conclusionUpon validation of an IHC protocol to stain TcRγδ+ IELs on FFPE duodenal sections that shows high sensitivity and specificity to discriminate CD patients from controls, this study establishes cut-off values for TcRγδ+ and CD3+ IELs on IHC-stained OCT and FFPE sections, showing highly comparable results for both embedding methods. Notably, this will widen the use of TcRγδ+ IELs density assessment in clinical practice, allowing a more precise diagnostic definition of difficult CD cases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.